SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-22-010214
Filing Date
2022-03-15
Accepted
2022-03-15 07:16:15
Documents
101
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K syrs-10k_20211231.htm   iXBRL 10-K 4345818
2 EX-4.1 syrs-ex41_82.htm EX-4.1 19517
3 EX-10.10 syrs-ex1010_83.htm EX-10.10 91383
4 EX-10.11 syrs-ex1011_80.htm EX-10.11 56370
5 EX-10.12 syrs-ex1012_81.htm EX-10.12 43358
6 EX-23.1 syrs-ex231_8.htm EX-23.1 9694
7 EX-31.1 syrs-ex311_11.htm EX-31.1 17539
8 EX-31.2 syrs-ex312_6.htm EX-31.2 17479
9 EX-32.1 syrs-ex321_9.htm EX-32.1 7661
10 EX-32.2 syrs-ex322_10.htm EX-32.2 7806
  Complete submission text file 0001564590-22-010214.txt   14416638

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA syrs-20211231.xsd EX-101.SCH 88876
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE syrs-20211231_cal.xml EX-101.CAL 81273
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE syrs-20211231_def.xml EX-101.DEF 316023
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE syrs-20211231_lab.xml EX-101.LAB 658187
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syrs-20211231_pre.xml EX-101.PRE 557398
95 EXTRACTED XBRL INSTANCE DOCUMENT syrs-10k_20211231_htm.xml XML 2551213
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37813 | Film No.: 22739109
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences